Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid versus hyaluronidase versus placebo injection for mild to moderate carpal tunnel syndrome
IRCT20170311033000N5Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hyaluronic acid, hyaluronidase, lidocaine and sodium chloride in carpal tunnel syndrome (CTS) (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Symptom Severity Scale index based on Boston Carpal Tunnel Syndrome Questionnaire and Functional Severity Scale index based on Boston Carpal Tunnel Syndrome Questionnaire. Started Aug 2024; status: completed.
02
Drugs
hyaluronic acidhyaluronidaselidocainesodium chloride
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on IRCT20170311033000N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170311033000N5.